Balyasny Asset Management LLC Amphastar Pharmaceuticals, Inc. Transaction History
Balyasny Asset Management LLC
- $57.8 Billion
- Q1 2025
A detailed history of Balyasny Asset Management LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 162,138 shares of AMPH stock, worth $4.02 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
162,138Holding current value
$4.02 Million% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding AMPH
# of Institutions
259Shares Held
33.6MCall Options Held
20.8KPut Options Held
11.6K-
Black Rock Inc. New York, NY5.94MShares$147 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$60.1 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$54.8 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$39.8 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$33.6 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.22B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...